baber/WOPTO huggingface dataset:
Patent ES-527540-A0 (ES)
IPC: H01H1/36
Filed: 1983-11-25
Abstract: 1. Contact arrangement for tap selectors of tapped transformers for the selective bridging-over of an inner contact ring (1) with tap contacts (5) arranged on an outer circle, with the following features : - two contact bridges (2, 3), which lie opposite each other and are pressable against each other by springs (4) of flat material, each lie constantly by a respective end (21, 31) against the contact ring (1), - the contact bridges are pivotable laterally from tap contact (5) to tap contact, - the contact ring (1) is encompassed by the inwardly fromed ends (21, 31) of both the contact bridges in such a manner that two contact places (6 or 7), lying one behind the other in longitudinal direction of the contact bridges, are present each time at the contact ring (1), - the tap contacts (5) are constructed as contact rods (5) of substantially round cross-section and extending in longitudinal direction of the contact bridges, - the free ends (22, 32) of both the contact bridges (2, 3) between them in the switched state receive a tap contact (5) by means of V-shaped inward formations, in such a manner that two contact places (8 or 9), which are displaced through 90 degrees at the contact ring relative to the contact places (6 or 7), respectively are likewise present, - the free ends of the contact bridges (2, 3) are provided with run-up surfaces (10 or 11) bent away outwardly for the better running-up onto the contact rod (5), - all contact places (6, 7, 8, 9) to be formed by the contact bridges (2, 3) are formed as raised stamped portions, characterised thereby, that the middle part of each contact bridge (2, 3) does not participate in the contact making and displays a cross-section which is bowed towards the other contact bridge, wherein both the bowed surfaces of both the contact bridges lie one against the other in the un-switched state and are rollable one on the other during the running-up onto the contact rod (5).
Patent ES-543916-A0 (ES)
IPC: C12P21/02
Filed: 1985-06-05
Abstract: The invention relates to a process for the isolation and purification of  alpha -interferons generated by plasmids from bacterial cultures which have been modified by genetic engineering, and of  alpha -interferons from culture supernatants of induced mammalian cells, which comprises partition of appropriate crude substances containing interferon between an aqueous urea solution, which contains a surfactant, and a mixture of n-butanol and glacial acetic acid which contains water, and isolation of the purified  alpha -interferons from the upper phase.
Patent ES-546809-A0 (ES)
IPC: C10G47/34
Filed: 1985-09-09
Abstract: Visbreaking of heavy residual oil is carried out at high severity in the presence of an organic sulfur compound containing a thiol group and a highly aromatic hydrogen donor material having HAr and H hydrogen contents each of at least 20% of the total hydrogen content.
Patent ES-551839-A0 (ES)
IPC: C01B3/44
Filed: 1986-02-11
Abstract: Process for the preparation of hydrogen-containing gas from hydrocarbons (e.g. methane) and steam and/or CO2 wherein the hydrocarbons and the steam and/or the CO2 are continuously converted in at least one reaction zone at elevated temperature and pressure into H2 and CO by continuously contacting the reactants with at least one fluidized bed of heated solid particles, which are then led continuously to a heating zone where they are continuously heated in a fluidized state by combustion of a part of the obtained H2 and/or of at least a part of the obtained CO with oxygen-containing gas, and which are finally led continuously back to the reaction zone(s) where they are again contacted with the reactants.
Patent ES-557245-A0 (ES)
IPC: C07C57/30
Filed: 1986-12-04
Abstract: Novel polyprenyl compounds terminated with a group of 
<CHEM>
 in which X, m, and R are as defined in the specification, processes for preparing them, pharmaceutical composition containing them, and use of them for the preparation of a medicament having antihypercholesterolemic activity for the treatment of arteriosclerosis are described.
Patent FI-832322-A0 (FI)
Inventor: HUTTON THOMAS WATKINS
IPC: C08L33/06
Filed: 1983-06-23
Abstract: Polymer composition, useful as or in binders, coatings or adhesives, comprises (A) carboxylic acid copolymer emulsion and (B) halohydroxypropyl- and/or glycidylammonium salt polymer wherein the polymer molecules are sufficiently swollen as to readily react with and penetrate interstices amongst emulsion (A) on drying the mixture. Coatings, binders or adhesives employing the composition are activated by base for coating or impregnating substrates, particularly non-woven fabric or fabric laminate, whereupon on drying and curing the mixture the polymer becomes crosslinked and insoluble.
Patent FI-832468-A0 (FI)
Inventor: COLLIOPOULOS JOHN
IPC: A23L27/29
Filed: 1983-07-05
Abstract: A composition and method for heat stabilizing dipeptide sweeteners for baking and cooking is described using a polyglucose or a polymaltose.
Patent FI-851109-A0 (FI)
Inventor: CARLSSON LARS
IPC: B65D5/72
Filed: 1985-03-20
Abstract: Opening arrangements for packing containers often comprise a prepunched hole which is covered by a tear-off cover strip. To facilitate the pouring out of liquid contents a so-called pouring rim is frequently present too, that is to say a material strip which forms a projecting rim over which the contents can run. The application of the pouring rim as well as the manufacture of the opening arrangement as a whole are facilitated by joining in advance the pouring rim in a detachable manner to the cover strip, whereafter the cover strip and the pouring rim can be applied as a unit.
Patent FI-880629-A0 (FI)
Inventor: REYNOLDS ERIC CHARLES
IPC: A23L29/00
Filed: 1988-02-11
Abstract: ep87305hopeptide or a salt thereof the phosphopeptide having from 5 to 30 amino acids including the sequence A-B-C-D-E where A, B, C, D and E are independently phosphoserine, phosphothreonine, phosphotyrosine, phosphohistidine, glutamate and aspartate and compositions particularly compositions to teeth including same.
Patent FI-893570-A0 (FI)
Inventor: TERADA ATSUSUKE
IPC: A61P1/04
Filed: 1989-07-26
Abstract: Compounds of formula (I): <CHEM> [in which: R<1> and R<2> are hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, aralkyl, arylalkenyl, aryl, aromatic heterocyclic, cyano or halogen: R<3> is hydrogen, optionally substituted alkyl, aralkyl or acyl; R<4> and R<5> are hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, aralkyl, arylalkenyl, aryl or aromatic heterocyclic]; and pharmaceutically acceptable salts thereof are analgesics and anti-inflammatory agents as well having anti-ulcer and 5-lipoxygenase inhibitory activities.
Patent FI-913535-A0 (FI)
Inventor: FRIEND ALDEN EMERSON
IPC: F16K17/38
Filed: 1991-07-23
Abstract: A fire isolation device having a valve designed to close after a given temperature has been reached by a fusible nose member in the form of a sleeve of fusible material. The device has a passageway therethrough and a self-closing valve member having a poppet and a seat disposed in the passageway with the poppet being biased toward the seat to a valve closed position. At least one aperture through the nose member provides for continuous fluid flow through the device around the poppet and the seat. The nose member is positioned to hold the valve in an open position against the bias on the poppet. The seat has a flow path on its outer end dimensioned to fit the nose member and a flow path towards its inner end larger in diameter than the nose member in an area occupied by the aperture to permit flow therethrough when the nose member holds the valve in an open position. The nose member is made of a material designed to melt in the neighborhood of 700 DEG  F. when the fire isolation device is exposed to 2000 DEG  F. for 15 minutes, for example, after which it will collapse into the larger diameter permitting the bias to close the valve. The nosse member is designed to melt prior to an attached component in order to prevent fluid leakage at the component. The remainder of the parts of the device are made of a higher temperature resistant material. In a second embodiment a bi-directional device is provided in which valve and nose members are positioned in both ends thereof.
Patent FI-941112-A0 (FI)
Inventor: BEVEN JOHN LAWSON
IPC: A24D3/16
Filed: 1994-03-09
Abstract: An extruded filtration material which is degradable and comprises or an inorganic material having a melting point above the operating temperature, a polysaccharide expansion medium, a binder and water. These ingredients are fed to an extruder and subjected to an extrusion process which involves a pressure reduction, upon extrusion from the exit die, of up to about 70 bars so that swelling of the extrudate occurs to give a cellular structure. When exposed to the natural weather conditions, tobacco smoke filter elements comprising such material degrade without leaving a fused amalgamation of inorganic material. <IMAGE>
Patent FI-964986-A0 (FI)
Inventor: SCHOFIELD JOHN DAVID
IPC: C09D7/45
Filed: 1996-12-12
Abstract: A dispersant for aqueous mill-bases obtainable by reacting a polyethylene glycol with a molar excess of a hydroxycarboxylic acid containing from 4 to 17 carbon atoms or lactone thereof and/or with a C3-4-alkylene oxide to form a polymeric diol and phosphating the diol. The preferred hydroxycarboxylic acid or lactone is epsi-caprolactone.
Patent FI-971714-A0 (FI)
Inventor: LIPPONEN JUHA
IPC: D21F5/04
Filed: 1997-04-22
Abstract: A method and an equipment for evaporation drying of the paper web that comes from the press section (10) of a paper machine. The method consists of three successive stages I, II and III that are carried out in the direction of progress of the web (W) as follows: (I) in the first stage, the paper web coming from the press section (10) of the paper machine is heated in a short section (L1) of the paper machine in the machine direction quickly to a temperature of 55...85  DEG C, and web breaks of the relatively moist and, thus, weak web (W) are minimized; (II) after the first stage (I), the main evaporation drying of the web (W) is carried out so that the evaporation efficiency (PE) and the rate of increase in the dry solids content (KA) of the web (W) are substantially higher than in the first stage or in the final stage (III), and the web temperature (TW) does substantially not rise while the drying proceeds (Fig. 4); (III) in the final stage, the drying is continued with a decreasing evaporation efficiency (Fig. 3) and with such an average rate of increase in the dry solids content (KA) of the web (W) in the machine direction as is lower than in the preceding stage (II) but higher than in a conventional cylinder drying with single-wire draw so that the paper quality can be controlled at the same time.
Patent FI-972390-A0 (FI)
Inventor: CERRETTI DOUGLAS P
IPC: C07K16/24
Filed: 1997-06-05
Abstract: The invention is directed to a protein designated Lerk-7, DNA encoding the Lerk-7, and host cells transformed with Lerk-7 DNA. Antibodies directed against Lerk-7 are also provided. The Lerk-7 protein binds to the cell surface receptors known as elk and hek.
Patent FI-990408-A0 (FI)
IPC: D21F7/04
Filed: 1999-02-25
Abstract: The invention relates to a monitoring system for web breaks in a paper machine. A web (W) is monitored by means of a number of cameras (1) and the image data of various camera positions is used for compiling focused image regions (12). Camera-specific image processing equipment (2, 12) is adapted to compile image change data by comparing the change between sequential images as far as the focused image region (12) is concerned. The image change data is compared with a normal level of image change and an alarm message (3a) is delivered if the image change level has a deviation from the reference level which exceeds a preset threshold value. A break alarm is set off, in case said alarm message (3a) is delivered by image change data comparators (3) of one or more pre-selected camera positions (P1-Pn). <IMAGE>
Patent IL-60506-A0 (IL)
Title: Herbicidal quinoxaline derivatives
IPC: C07D241/44
Filed: 1980-07-06
Abstract: The invention concerns novel compounds of the formula I <CHEM>   The compounds are herbicides and in further embodiments the invention provides processes for the preparation of compounds of formula I, intermediates useful in the preparation of compounds of formula I, herbicidal compositions containing as active ingredient a compound of formula I, and processes for severely damaging or killing unwanted plants by applying to the plants or to the growth medium of the plants an effective amount of a compound of formula I.
Patent IL-66094-A0 (IL)
Title: Synthesis with multipolymer systems
IPC: C07C241/00
Filed: 1982-06-22
Abstract: A method and apparatus are provided for synthesizing organic compounds in which reactants A and B are bound to respective polymeric supports and P/ &cir&  and P'/ &cir& . Reactant A is bound to P/ &cir&  via a linking moiety  alpha  min  and an intermediate reactant  alpha  is circulated between the two polymeric supports. When  alpha  is fed to the first support  alpha -A is formed and when  alpha -A is fed to the second support P'/ &cir& -B-A is formed and free  alpha  regenerated. When sufficient P min -B-A is formed, the circulation is stopped and B-A separated and removed.
Patent IL-67705-A0 (IL)
Title: Amide derivatives
IPC: C07D409/14
Filed: 1983-01-17
Abstract: Amide derivatives of the formula:  <IMAGE>  wherein either R1 is aryl or heterocyclic and A1 is a direct link, or R1 is aryl or heterocyclic, or hydrogen, or halogeno, hydroxy, amino, guanidino, mercapto, carboxy, carbamoyl, or a substituted derivative thereof, and A1 is alkylene, alkenylene, cycloalkylene or cycloalkenylene; wherein X is carbonyl or hydroxymethylene or substituted derivatives thereof; wherein A2 is alkylene, alkenylene or alkylidene; wherein R2 is hydrogen or alkyl which is unsubstituted or which bears an aryl substituent, or R2 has the formula -Q2-R20 as defined below; wherein R3 is hydrogen, alkyl or a carbonyl-containing group; wherein R4 is hydrogen or alkyl which is unsubstituted or which bears a halogeno, hydroxy, amino, guanidino, carboxy, carbamoyl, mercapto, alkoxy, alkylamino, dialkylamino, cyclic amino, alkylthio, alkanoylamino, alkoxycarbonylamino, alkoxycarbonyl, alkoxycarbonyl, aryl or heterocyclyl substituent; wherein -NR5-CR6R16-Q1-R10 is an amino acid residue, R5, R6 and R16 being defined in claim 1, wherein Q1 and Q2, which may be the same or different, each is carbonyl (-CO-) or methylene (-CH2-); and wherein R10 and R20, which may be the same or different, is hydroxy, amino or a substituted derivative thereof or hydroxyamino or arylthio; or a salt thereof where appropriate; processes for their manufacture and pharmaceutical compositions containing them. The compounds are inhibitors of angiotensin converting enzyme and may be used in the treatment of hypertension.
Patent IL-68349-A0 (IL)
Title: Chimeric cloning vectors for use in streptomyces and e.coli
IPC: C12N15/09
Filed: 1983-04-11
Abstract: There is described a recombinant DNA cloning vector useful in Streptomyces and E. coli, comprising   a) a functional origin of replication- containing restriction fragment of plasmid SCP2 or SCP2*, b) a restriction fragment comprising an E. coli origin of replication, c) one or more DNA segments that confer resistance to at least one antibiotic when transformed into a cell of E. coli, said cell being sensitive to the antibiotic for which resistance is conferred, and d) one or more DNA segments that independently confer either or both of the Streptomyces tra function or resistance to at least one antibiotic when transformed into a cell of Streptomyces, said cell being sensitive to the antibiotic for which resistance is conferred.   Transformants and a method for detecting transformants of the vector are also disclosed.
Patent IL-70498-A0 (IL)
Title: Vasotocin derivatives
IPC: A61P5/00
Filed: 1983-12-20
Abstract: Novel vasotocin derivatives having an inhibitory effect on uterine contractions, pharmaceutical compositions containing these derivatives, and the use thereof in the therapeutical treat- nent of excessive muscle contractions in the uterus are described. The derivatives differ from vasotocin in that the structure of the original hormone has been modified at positions 1, 2 and, optionally, 4 and/or 8. The vasotocin derivatives thus iave the formulawhereinMpa is a 3-mercaptopropionyl residue (-S-CH<sub>2</sub>- CH<sub>2</sub>-CO-);A is the peptide residue of L- or D-tyrosine-O-ethyl ether (in other words, 4-ethoxy-L or D-phenyl alanine, i.e. L-or D-Tyr(Et)), or of a hydrophopic D-amino acid, such as D-tyrosine(D-Tyr) or D-tryptophane(D-Trp);Ile is the peptide residue of isoleucine;B is the peptide residue of glutamine (Gin), treonine (Thr) or valine (Val);Asn is the peptide residue of asparagin;Cys is the peptide residue of cysteine;Pro is the peptide residue of proline;C is the peptide residue of L- or D-arginine (Arg), ornithine (Orn) or citrullin (Cit); andGly-NH<sub>2</sub> is the peptide residue of glycine amide.
Patent IL-71425-A0 (IL)
Title: Preparation of symmetrical 1,4-dihydropyridinedicarboxylic esters
IPC: C07C205/56
Filed: 1984-04-02
Abstract: 1. Processs for the preparation of symmetrical 1,4-dihydropyridines of the formula I  see diagramm : EP0124742,P6,F1  in which R represents a phenyl radical which is optionally mono- or disubstituted by nitro and/or chlorine, and R1  represents a C1 -C4 -alkyl radical which is optionally substituted by a C1 -C4 -alkoxy group, by reaction of an ylidene compound of the formula II  see diagramm : EP0124742,P6,F2  with an enamine compound of the formula III  see diagramm : EP0124742,P6,F3  characterized in that the ylidene compound of the formula II is prepared by reaction of a ketocarboxylic ester of the formula IV  see diagramm : EP0124742,P6,F4  with an aldehyde of the formula RCHO in a solvent, in the presence of catalytic amounts of piperidine acetate, at temperatures from - 10 degrees C and up to 100 degrees C.
Patent IL-73384-A0 (IL)
Title: Macrocyclic lactones,their preparation and their use as pesticides
IPC: C07D311/00
Filed: 1984-10-31
Abstract: Milbemycin derivatives of the formula I    <IMAGE>  (I)  wherein A has the structure   <IMAGE>  or the structure   <IMAGE>  X is either -CH(OR1)- or -CO-, R1 is hydrogen, a silyl group or an acyl group, and R2 is methyl, ethyl, isopropyl or sec-butyl, can be prepared by singulett oxygen oxidation of the milbemycin derivatives of the formula II herein, wherein X and R2 have the above meanings, and subsequent reduction of the 15- and 14-peroxides obtained as intermediates. Compounds of the formula I can be prepared as such or in the form of compositions for controlling endo- and ectoparasites, in particular nematodes which are parasites of animals.
Patent IL-73781-A0 (IL)
Title: Rodenticides containing a 3-substituted-4-hydroxycoumarin isomer
IPC: A01N43/14
Filed: 1984-12-10
Abstract: Improved rodenticidal compositions comprise an edible carrier and a rodenticidally effective amount of an isomer of a 3-substituted-4-hydroxycoumarin capable of existing in more than one stable isomeric form characterised in that the isomer is one which when compared with any other isomer or isomers is significantly less persistently retained in the tissues of non-rodent mammalian or avian species likely to consume either rodenticidal bait formulations or poisoned rodent carcasses the compositions being substantially free of the other isomer or isomers.
Patent IL-78208-A0 (IL)
Title: 5-fluorobenzonitrile derivatives and pharmacologically acceptable acid addition salts thereof for increasing the lean meat to fat ratio,and/or enhancing the growth rate of warm-blooded animals
IPC: A61P3/00
Filed: 1986-03-20
Abstract: There are provided novel 5-fluorobenzonitrile derivatives which exhibit low β<sub>1</sub> heart stimulant activity and are useful for increasing the lean meat to fat ratio and/or enhancing the growth rate of warm-blooded animals by, orally or parenterally, administering to said animals an amount of a 5-fluorobenzonitrile derivative or a pharmacologically acceptable salt thereof effective for achieving one or more of the above-identified metabolic improvements in said warm-blooded animals.
Patent IL-84660-A0 (IL)
Title: Bicyclic diphosphonate compounds and pharmaceutical compositions containing them
IPC: A61P3/14
Filed: 1987-11-30
Abstract: The present invention relates to novel compounds having nitrogen-containing, saturated bicyclic cylopentane-fused rings which are geminally disubstituted with phosphonate groups. Most preferred compounds of the present invention have the general structure: <CHEM>   The present invention further relates to pharmaceutical compositions containing these novel compounds. Finally, this invention relates to methods for treating or preventing diseases characterized by abnormal calcium and phosphate metabolism by utilizing a compound or pharmaceutical composition of the present invention.
Patent IL-90912-A0 (IL)
Title: Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
IPC: C07D215/18
Filed: 1989-07-10
Abstract: Compounds of the formula 
<IMAGE>
 in which the symbols R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, n, X and Y have the meaning indicated in the description, can be used as medicines for oncological and dermatological indications.
Patent IL-91342-A0 (IL)
Title: Solid silicone agricultural compositions with biological action
IPC: A01N25/22
Filed: 1989-08-17
Abstract: Solid compositions having a biological action in agriculture. They comprise a silicone elastomer matrix in which there is distributed an active substance having a biological action in agriculture in water-soluble form. Application in agriculture.
Patent IL-94903-A0 (IL)
Title: N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe-and phenethylamine derivatives and pharmaceutical compositions containing them
IPC: A61K31/335
Filed: 1990-06-28
Abstract: Novel unnatural dipeptoids of  alpha -substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further the compounds are antianxiety agents and antiulcer agents and are agents useful for preventing the withdrawal response produced by chronic treatment or use followed by chronic treatment followed by withdrawal from nicotine, diazepam, alcohol or cocaine. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare pharmaceutical and diagnostic compositions.
Patent AU-PR399001-A0 (AU)
Title: An apparatus and method(ART104)
IPC: B41J2/175
Filed: 2001-03-27
Abstract: A method for assembling a modular printhead assembly having an ink delivery member and a plurality of printhead modules received in a channel at a predetermined pitch is disclosed. The method includes the steps of flexing the channel apart at a first location to enable receipt of a first printhead module into the channel at the first location, the step of flexing being performed against a pivot point located along a centerline of an underside of the channel; and flexing apart a first capping device to enable pushing of the first capping device over the first printhead module.